Efonidipine, a long-acting dihydropyridine derivative, attenuates coronary vasoconstriction induced by endothelin-1 in dogs

Japanese Journal of Pharmacology

Volumn 72, Issue 4, 1996, Pages 291-297

  Yokoyama, Tatsuro ^a   Ichihara, Kazuo ^a,b   Abiko, Yasushi ^a  

^a ASAHIKAWA MEDICAL COLLEGE   (Japan)

^b HOKKAIDO INSTITUTE OF TECHNOLOGY   (Japan)

Author keywords

Angiography; Calcium channel blocker; Coronary blood flow; Efonidipine; Endothelin 1

Indexed keywords

DIHYDROPYRIDINE DERIVATIVE; EFONIDIPINE; ENDOTHELIN 1;

ANGIOCARDIOGRAPHY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY DIAMETER; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; CORONARY ARTERY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY CONSTRICTION; DIASTOLIC BLOOD PRESSURE; DOG; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG STRUCTURE; FEMALE; HEART RATE; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; SYSTOLIC BLOOD PRESSURE;

EID: 0030474077     PISSN: 00215198     EISSN: None     Source Type: Journal    
DOI: 10.1254/jjp.72.291     Document Type: Article

References (23)

1. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K and Masaki T: A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332, 411-415 (1988)
2. Itoh Y, Yanagisawa M, Ohkubo S, Kimura C, Kosaka T, Inoue A, Ishida N, Mitsui Y, Onda H, Fujino M and Masaki T: Cloning and sequence analysis of cDNA encoding the precursor of a human endothelium-derived vasoconstrictor peptide, endothelin: Identity of human and porcine endothelin. FEBS Lett 231, 440-444 (1988)
3. Kasuya Y, Ishikawa T, Yanagisawa M, Kimura S, Goto K and Masaki T: Mechanism of contraction to endothelin in isolated porcine coronary artery. Am J Physiol 251, H1828-H1835 (1989)
4. Igarashi Y, Aizawa Y, Tamura M, Ebe K, Yamaguchi T and Shibata A: Vasoconstrictor effect of endothelin on the canine coronary artery: Is a novel endogenous peptide involved in regulating myocardial blood flow and coronary spasm? Am Heart J 118, 674-678 (1989)
5. Kurihara H, Yamaoki K, Nagai R, Yoshizumi M, Takaku F, Satoh H, Inui J and Yazaki Y: Endothelin: A potent vasoconstrictor associated with coronary vasospasm. Life Sci 44, 1937-1943 (1989)
6. Ezra D, Goldstein RE, Czaja JF and Feuerstein GZ: Lethal ischemia due to intracoronary endothelin in pigs. Am J Physiol 257, H339-H343 (1989)
7. Toyo-oka T, Aizawa T, Suzuki N, Hirata Y, Miyaguchi T, Shin WS, Yanagisawa M, Masaki T and Sugimoto T: Increased plasma level of endothelin-1 and coronary spasm induction in patients with vasospastic angina pectoris. Circulation 83, 476-483 (1991)
8. Lücher TF: Endothelin: Key to coronary vasospasm? Circulation 83, 701-703 (1991)
9. Ohio S and Specchia G: Clinical evaluation of calcium-antagonist drugs. J Cardiovasc Pharmacol 20, Supp 7, S71-S74 (1992)
10. Masuda Y and Tanaka S: Efonidipine hydrochloride: a new calcium antagonist. Cardiovasc Drug Rev 12, 123-135 (1994)
11. Masuda Y, Iwama T, Yamashita T, Sakai T, Hibi M, Tanaka S, Shigenobu K and Kasuya Y: Vasorelaxing and receptor binding properties of NZ-105, a novel dihydropyridine derivative, in isolated rabbit aorta. Arch Int Pharmacodyn Ther 312, 86-103 (1991)
12. Sakai T, Kawamura N, Masuda Y, Hibi M and Tanaka S: Hemodynamic effects of the new dihydropyridine derivative (±)-2-[benzyl(phenyl)amino]ethyl 1,4-dihydro-2,6-dimethyl-5-(5,5-dimethyl-2-oxo-1,3,2-dioxaphosphorinan-2-yl)-4- (3-nitrophenyl)-3-pyridinecarboxylate hydrochloride ethanol (NZ-105) in anesthetized dogs. Ôyô Yakuri/Pharmacometrics 42, 43-54 (1991) (Abstr in English)
13. Stasch JP and Kazda S: Endothelin-1-induced vascular contractions: Interactions with drugs affecting the calcium channel. J Cardiovasc Pharmacol 13, Supp 5, S63-S66 (1989)
14. 2+ channel in vascular smooth muscle. Proc Natl Acad Sci USA 86, 3915-3918 (1989)
15. Kurihara H, Yoshizumi M, Sugiyama T, Yamaoki K, Nagai R, Takaku F, Satoh H, Inui J, Yanagisawa M, Masaki T and Yazaki Y: The possible role of endothelin-1 in the pathogenesis of coronary vasospasm. J Cardiovasc Pharmacol 13, Supp 5, S132-S137 (1989)
16. Clozel JP and Clozel M: Effects of endothelin on the coronary vascular bed in open-chest dogs. Circ Res 65, 1193-1200 (1989)
17. Egashira K, Pipers FS, Rush JE and Morgan JP: Effects of calcium channel blockers on coronary vasoconstriction induced by endothelin-1 in closed chest pigs. J Am Coll Cardiol 16, 1296-1303 (1990)
18. Nichols AJ, Koster PF and Ohlstein EH: The effect of diltiazem on the coronary haemodynamic and cardiac functional effects produced by intracoronary administration of endothelin-1 in the anaesthetized dog. Br J Pharmacol 99, 597-601 (1990)
19. Van Renterghem C, Vigne P, Barhanin J, Schmid-Alliana A, Frelin C and Lazdunski M: Molecular mechanism of action of the vasoconstrictor peptide endothelin. Biochem Biophys Res Commun 157, 977-985 (1988)
20. Sakata K, Ozaki H, Kwon SC and Karaki H: Effects of endothelin on the mechanical activity and cytosolic calcium levels of various types of smooth muscle. Br J Pharmacol 98, 483-492 (1989)
21. Ohlstein EH, Horohonich S and Hay DWP: Cellular mechanisms of endothelin in rabbit aorta. J Pharmacol Exp Ther 250, 548-555 (1989)
22. Kasuya Y, Takuwa Y, Yanagisawa M, Kimura S, Goto K and Masaki T: Endothelin-1 induces vasoconstriction through two functionally distinct pathways in porcine coronary artery: Contribution of phosphoinositide turnover. Biochem Biophys Res Commun 161, 1049-1055 (1989)
23. Masuda Y, Takeguchi M, Arakawa C, Sakai T, Hibi M, Tanaka S, Shigenobu K and Kasuya Y: Antihypertensive and diuretic effect of NZ-105, a novel dihydropyridine derivative. Arch Int Pharmacodyn Ther 304, 247-264 (1990)